These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 717986)

  • 1. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
    Lokich JJ; Zamcheck N; Lowenstein MW
    Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
    Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
    J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
    Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
    Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
    Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
    Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
    Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
    JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
    Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
    Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ; Ahlemann LM; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels.
    Lokich JJ; Ellenberg S; Gerson B
    J Clin Oncol; 1984 Mar; 2(3):181-6. PubMed ID: 6699670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Ohkura H; Suemasu K
    Cancer; 1986 Apr; 57(7):1318-23. PubMed ID: 3004689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
    Tormey DC; Waalkes TP; Snyder JJ; Simon RM
    Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
    Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
    Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic validity of CEA determination in metastasizing breast cancer].
    Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
    Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial tests of carcinoembryonic antigen in patients with breast cancer.
    Lee YT
    Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
    Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
    Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
    Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
    J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer.
    Ichiki AT; Krauss S; Israelsen KL; Sonoda T; Collmann IR
    Oncology; 1981; 38(1):27-30. PubMed ID: 7443173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.